| Literature DB >> 25806037 |
Diana Sánchez-Rangel1, Mariana Rivas-San Vicente1, M Eugenia de la Torre-Hernández1, Manuela Nájera-Martínez1, Javier Plasencia1.
Abstract
The field of plant sphingolipid biology has evolved in recent years. Sphingolipids are abundant in cell membranes, and genetic analyses revealed essential roles for these lipids in plant growth, development, and responses to abiotic and biotic stress. Salicylic acid (SA) is a key signaling molecule that is required for induction of defense-related genes and rapid and localized cell death at the site of pathogen infection (hypersensitive response) during incompatible host-pathogen interactions. Conceivably, while levels of SA rapidly increase upon pathogen infection for defense activation, they must be tightly regulated during plant growth and development in the absence of pathogens. Genetic and biochemical evidence suggest that the sphingolipid intermediates, long-chain sphingoid bases, and ceramides, play a role in regulating SA accumulation in plant cells. However, how signals generated from the perturbation of these key sphingolipid intermediates are transduced into the activation of the SA pathway has long remained to be an interesting open question. At least four types of molecules - MAP kinase 6, reactive oxygen species, free calcium, and nitric oxide - could constitute a mechanistic link between sphingolipid metabolism and SA accumulation and signaling.Entities:
Keywords: ceramide; salicylic acid; sphinganine-analog mycotoxin; sphingoid bases; sphingolipid
Year: 2015 PMID: 25806037 PMCID: PMC4353297 DOI: 10.3389/fpls.2015.00125
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Association between sphingolipid metabolism and salicylic acid (SA) levels.
| Gene name | Gene ID | Gene product | Sphingolipid profile in mutant or silenced plants | SA levels in mutant or silenced plants | Reference | |
|---|---|---|---|---|---|---|
| NbLCB2 AM902524 | Serine palmitoyl transferase (SPT) | 50% reduction of trihydroxylated long-chain base (LCBs). Fourfold increase of dihydroxylated LCBs | 1.5-fold increase in total SA levels | Constitutive | ||
| At3g25540 | Ceramide synthase | Higher percentage of ceramides (7%) and glucosylceramides (19%) containing C16 fatty acids. Fivefold elevation of trihyhdroxy-LCBs | SA levels are unaffected | Constitutive; 160-fold raise | ||
| At2g34770/ At4g20870 | Fatty acid hydroxylase (FAH) | Fivefold increase of trihydroxylated LCBs; 100-fold reduction of hydroxyceramides; two- to fourfold reduction of phytoglucosylceramides, 10-fold increase of phytoceramides | 3.2-fold higher levels of free SA enriched and 4.3-fold increase in SA conjugates | Constitutive | ||
| At3G21630 | Ceramide kinase | Two- to sixfold increase in ceramides and hydroxy-ceramides; no changes in glucosylceramides and LCBs levels | Fourfold increase in free SA and ninefold raise in total SA | Constitutive, but impaired induction. | ||
| At2g37940 | Inositol –P-ceramide synthase 2 | Two- to threefold increase in ceramides and hydroxyceramides. Enriched in trihydroxylated LCBs | Threefold higher levels of free SA and conjugated SA | Constitutive | ||
| At2g13650 | GDP-D-mannose transporter | 3.5-fold decrease in the proportion of Hex1GIPCs in membranes. Most (75%) of glycosyl inositol phosphorylceramides (GIPCs) found lack hexosylation | Fourfold increase in free SA levels and sixfold increase in total SA | Constitutive; 10-fold raise. | ||
| At2g34690 | Ceramide-1-phosphate transfer protein | Sevenfold increase in ceramides; threefold rise in hydroxyceramides; twofold increase in GIPC and GlcCer; twofold increase in LCBs and LCB-P | 63-fold increase in total SA | Constitutive | ||